表紙
市場調查報告書

液體活檢的全球市場:主要公司的預測/分析(2020-2030)

Liquid Biopsy Market Report 2020-2030: Forecasts by Product (Instruments, Kits & Reagents, Services), Sample Type (Blood Samples, Urine Samples, Others), Biomarker, Cancer Type, End-user, Region, plus Analysis of Leading Companies

出版商 Visiongain Ltd 商品編碼 954230
出版日期 內容資訊 英文 462 Pages
商品交期: 最快1-2個工作天內
價格
液體活檢的全球市場:主要公司的預測/分析(2020-2030) Liquid Biopsy Market Report 2020-2030: Forecasts by Product (Instruments, Kits & Reagents, Services), Sample Type (Blood Samples, Urine Samples, Others), Biomarker, Cancer Type, End-user, Region, plus Analysis of Leading Companies
出版日期: 2020年06月09日內容資訊: 英文 462 Pages
簡介

在全球液體活檢市場上,技術進步,例如新生物標誌物的開發,對微創外科手術的偏好增加,對癌症的認識導致癌症病例增加,新興經濟體的可支配收入增加等。是政治上的主要因素。此外,預計在不久的將來使用液體活檢進行癌症篩查的預篩查計劃的增加將為大公司提供新的市場機會。

本報告研究和分析了全球液體活檢市場,並提供了有關市場概況,按細分市場劃分的市場前景,按地區和主要國家以及主要公司進行的市場分析的系統信息。

目錄

第1章報告概述

第2章執行摘要

第3章市場前景

  • 簡介
  • 液體活檢行業:增長因素
    • 癌症患病率上升
    • 人口老齡化增加
    • 對安全和微創治療的需求不斷增長
    • 液體活檢的好處和成本效益
  • 液體活檢行業:抑制要因
    • 贖回差距
    • 嚴格監管的環境
  • 液體活檢行業的未來機會
    • 通過合作/合同增加公司在全球市場的參與度
    • 液體活檢測試的發展進展
  • 液體活檢行業:監管狀況
  • 液體活檢行業:最新趨勢
    • 人工智能技術的出現
    • 液體活檢被認為是最重要的癌症突破療法之一
    • 多目標液體活檢:2019年值得關注的新臨床試驗
  • 液體活檢行業:PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 環境
    • 技術
    • 合法
  • 液體活檢行業:SWOT分析
    • 優勢
    • 弱點
    • 市場機會
    • 威脅
  • 液體活檢行業:波特的五力分析
  • COVID-19對液體活檢行業的影響

第4章按產品分類的液體活檢市場

  • 按產品分列的市場前景
  • 試劑盒和試劑
  • 服務

第5章按樣本類型劃分的市場

  • 按樣本類型劃分的市場前景
  • 血液樣本
  • 尿液樣本
  • 其他

第6章生物標誌物市場

  • 生物標誌物的市場前景
  • 循環腫瘤細胞(CTC)
  • 循環腫瘤DNA(ctDNA)
  • 外來體
  • 其他

第7章按癌症類型劃分的市場

  • 癌症類型的市場前景
  • 乳腺癌
  • 大腸癌
  • 肝癌
  • 肺癌
  • 前列腺癌
  • 其他癌症

第8章最終用戶的市場

  • 最終用戶的市場前景
  • 醫院
  • 診斷實驗室
  • 學術機構
  • 癌症研究中心

第9章區域市場

  • 區域市場前景
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 俄羅斯
    • 波蘭
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 澳大利亞
    • 印度
    • 韓國
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 委內瑞拉
    • 墨西哥
    • 其他拉丁美洲
  • 中東/非洲
    • 沙特阿拉伯
    • 南非
    • 土耳其
    • 阿拉伯聯合酋長國
    • 其他中東/非洲地區

第10章公司簡介

  • 競爭形勢:液體活檢市場
  • 初創公司:液體活檢市場
  • Menarini Silicon Biosystems
    • 公司簡介
    • 財務狀況(2015-2018)
    • 產品
    • 最新趨勢
  • MDxHealth SA
    • 公司簡介
    • 財務狀況(2015-2018)
    • 產品
    • 最新趨勢
  • Biocept
    • 公司簡介
    • 財務狀況(2015-2018)
    • 產品
    • 最新趨勢
  • Trovagene
    • 公司簡介
    • 財務狀況(2015-2018)
    • 產品
    • 最新趨勢
  • Sysmex Corp
    • 公司簡介
    • 財務狀況(2015-2018)
    • 產品
    • 最新趨勢
  • F. Hoffmann-La Roche AG
    • 公司簡介
    • 財務狀況(2015-2018)
    • 產品
    • 最新趨勢
  • Bio-Rad Laboratories
    • 公司簡介
    • 財務狀況(2015-2018)
    • 產品
    • 最新趨勢
  • Guardant Health
    • 公司簡介
    • 財務狀況(2015-2018)
    • 產品
    • 最新趨勢
  • Illumina
    • 公司簡介
    • 財務狀況(2015-2018)
    • 產品
    • 最新趨勢
  • Myriad Genetics
    • 公司簡介
    • 財務狀況(2015-2018)
    • 產品
    • 最新趨勢
  • Qiagen NV
    • 公司簡介
    • 財務狀況(2015-2018)
    • 產品
    • 最新趨勢
  • Lineage Cell Therapeutics
    • 公司簡介
    • 財務狀況(2015-2018)
    • 產品
    • 最新趨勢
  • Abbott Laboratories
    • 公司簡介
    • 財務狀況(2015-2018)
    • 產品
    • 最新趨勢
  • Beckman Coulter(Danaher Corporation)
    • 公司簡介
    • 財務狀況(2015-2018)
    • 產品
    • 最新趨勢
  • Caris Life Sciences
    • 公司簡介
    • 產品
  • OPKO Health
    • 公司簡介
    • 財務狀況(2015-2018)
    • 產品
    • 最新趨勢
  • Thermo Fisher Scientific
    • 公司簡介
    • 財務狀況(2015-2018)
    • 產品
    • 最新趨勢
  • Johnson & Johnson
    • 公司簡介
    • 財務狀況(2015-2018)
    • 產品
    • 最新趨勢
  • Exact Sciences Corporation
    • 公司簡介
    • 財務狀況(2015-2018)
    • 產品
    • 最新趨勢
  • Vermillion
    • 公司簡介
    • 財務狀況(2015-2018)
    • 產品
    • 最新趨勢

第11章結論和建議

  • COVID-19的影響

第12章詞彙表

第13章附錄

  • 報告評估表
  • 採購訂單
  • 附錄A
  • 關於視覺增益
  • 附錄B
  • 報告評估表
目錄
Product Code: PHA0782

Title:
Liquid Biopsy Market Report 2020-2030
Forecasts by Product (Instruments, Kits & Reagents, Services), by Sample Type (Blood Samples, Urine Samples, Others), by Biomarker (Circulating Tumour Cell (CTC), Circulating Tumour DNA (ctDNA), Exosomes, Others), by Cancer Type (Breast Cancer, Colorectal Cancer, Liver Cancer, Lung Cancer, Prostate Cancer, Others), by End-user (Hospitals, Diagnostic Laboratories, Academic Institutions, Cancer Research Centres), by Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa), Plus Analysis of Leading Companies.

The main drivers for the growth include technological advancements such as development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies. Moreover, rising number of pre-screening programs for cancer detection using liquid biopsy are expected to provide new market opportunities to the key players in the near future.

This Visiongain report covers the global liquid biopsy market, including analysis of the market by product type, biomarker type, sample type, cancer type, end user and national markets for liquid biopsy products. We aim to provide a comprehensive and critical analysis of the market, assessing the market's potential from a variety of viewpoints. We examine the opportunities and challenges that exist within the market, as well as the major commercial trends. We also analyses the market prospects for different segments and provide an overview of the research and development in this sector.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

Liquid Biopsy Market Dynamics:

  • Increasing Prevalence of Cancer
  • Rising Ageing Population
  • Rising Demand for Safe and Minimally Invasive Procedures
  • Advantages of Liquid Biopsy and Cost Effectiveness
  • Disparity in Reimbursements
  • Strict Regulatory Environment
  • Increasing involvement of global market players through collaborations/agreements
  • Progress in the development of liquid biopsy tests

Liquid Biopsy Market Segmentation 2020-2030:

Segmentation by Product, 2020 - 2030 (USD Million)

  • Instruments
  • Kits & Reagents
  • Services

Segmentation by Sample Type, 2020 - 2030 (USD Million)

  • Blood Samples
  • Urine Samples
  • Others

Segmentation by Biomarker, 2020 - 2030 (USD Million)

  • Circulating Tumour Cell (CTC)
  • Circulating Tumour DNA (ctDNA)
  • Exosomes
  • Others

Segmentation by Cancer Type, 2020 - 2030 (USD Million)

  • Breast Cancer
  • Colorectal Cancer
  • Liver Cancer
  • Lung Cancer
  • Prostate Cancer
  • Others

Segmentation by End-User, 2020 - 2030 (USD Million)

  • Hospitals
  • Diagnostic Laboratories
  • Academic Institutions
  • Cancer Research Centres

Segmentation by Geography, 2020 - 2030 (USD Million)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Poland
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Venezuela
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • UAE
    • South Africa
    • Saudi Arabia
    • Rest of Middle East & Africa

Liquid Biopsy Market: Top 10 Companies

  • Menarini Silicon Biosystems, Inc.
  • MDxHealth SA
  • Biocept, Inc.
  • Trovagene, Inc.
  • Sysmex Inostics GmbH
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc.
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Myriad Genetics, Inc.

Buy our report today Liquid Biopsy Market Report 2020-2030: Forecasts by Product (Instruments, Kits & Reagents, Services), by Sample Type (Blood Samples, Urine Samples, Others), by Biomarker (Circulating Tumour Cell (CTC), Circulating Tumour DNA (ctDNA), Exosomes, Others), by Cancer Type (Breast Cancer, Colorectal Cancer, Liver Cancer, Lung Cancer, Prostate Cancer, Others), by End-user (Hospitals, Diagnostic Laboratories, Academic Institutions, Cancer Research Centres), by Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa), Plus Analysis of Leading Companies. Avoid missing out by staying informed - order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Global Liquid Biopsy Market Overview
  • 1.2. Why You Should Read This Report
  • 1.3. How This Report Delivers
  • 1.4. Key Questions Answered by This Analytical Report
  • 1.5. Who Is This Report For?
  • 1.6. Methodology
    • 1.6.1. Primary Research
    • 1.6.2. Secondary Research
    • 1.6.3. Market Evaluation & Forecasting Methodology
    • 1.6.4. Market Size Estimation
  • 1.7. Frequently Asked Questions (FAQ)
  • 1.8. Associated Visiongain Reports
  • 1.9. About Visiongain

2. Liquid Biopsy: Executive Summary

3. Liquid Biopsy Market Outlook

  • 3.1. Introduction
  • 3.2. Liquid Biopsy Industry: Drivers
    • 3.2.1. Increasing Prevalence of Cancer
    • 3.2.2. Rising Ageing Population
    • 3.2.3. Rising Demand for Safe and Minimally Invasive Procedures
    • 3.2.4. Advantages of Liquid Biopsy and Cost Effectiveness
  • 3.3. Liquid Biopsy Industry: Restraints
    • 3.3.1. Disparity in Reimbursements
    • 3.3.2. Strict Regulatory Environment
  • 3.4. Liquid Biopsy Industry Future Opportunities
    • 3.4.1. Increasing involvement of global market players through collaborations/agreements
    • 3.4.2. Progress in the development of liquid biopsy tests
  • 3.5. Liquid Biopsy Industry: Regulatory Landscape
  • 3.6. Liquid Biopsy Industry: Latest developments
    • 3.6.1. Emergence of artificial intelligence technologies
    • 3.6.2. Liquid biopsy is considered to be one of the most significant breakthrough treatments for cancer
    • 3.6.3. Multi-Target Liquid Biopsy would be a novel clinical test to watch out in 2019
  • 3.7. Liquid Biopsy Industry: PESTEL Analysis
    • 3.7.1. Political
      • 3.7.1.1. Regulatory Bodies
      • 3.7.1.2. Insurance / Reimbursement:
    • 3.7.2. Economic
    • 3.7.3. Social
    • 3.7.4. Environmental
    • 3.7.5. Technological
      • 3.7.5.1. Advent of New Technologies
      • 3.7.5.2. Early Stage Diagnosis of Cancer with Liquid Biopsies
      • 3.7.5.3. Improved Liquid Biopsy Techniques
      • 3.7.5.4. Comparison with Tissue Sampling
      • 3.7.5.5. Cost Reductions and Time Saving with Liquid Biopsies
    • 3.7.6. Legal
      • 3.7.6.1. Regulatory Science Challenge
      • 3.7.6.2. FDA
      • 3.7.6.3. Lawsuits and Litigations
  • 3.8. Liquid Biopsy Industry: SWOT Analysis
    • 3.8.1. Strength
    • 3.8.2. Weakness
    • 3.8.3. Opportunities
    • 3.8.4. Threats
  • 3.9. Liquid Biopsy Industry: Porter's Five Forces Analysis
  • 3.10. COVID-19 Impact on Liquid Biopsy Industry

4. Liquid Biopsy Market by Product

  • 4.1. Liquid Biopsy Market Outlook by Product
  • 4.2. Kits & Reagents
  • 4.3. Services

5. Liquid Biopsy Market By Sample Type

  • 5.1. Liquid Biopsy Market Outlook By Sample Type
  • 5.2. Blood Samples
  • 5.3. Urine Samples
  • 5.4. Others

6. Liquid Biopsy Market By Biomarker

  • 6.1. Liquid Biopsy Market Outlook By Biomarker
  • 6.2. Circulating Tumour Cell (CTC)
  • 6.3. Circulating Tumour DNA (ctDNA)
  • 6.4. Exosomes
  • 6.5. Others

7. Liquid Biopsy Market By Cancer Type

  • 7.1. Liquid Biopsy Market Outlook By Cancer Type
  • 7.2. Breast Cancer
  • 7.3. Colorectal Cancer
  • 7.4. Liver Cancer
  • 7.5. Lung Cancer
  • 7.6. Prostate Cancer
  • 7.7. Other Cancers

8. Liquid Biopsy Market By End-User

  • 8.1. Liquid Biopsy Market Outlook By End-User
  • 8.2. Hospitals
  • 8.3. Diagnostic Laboratories
  • 8.4. Academic Institutions
  • 8.5. Cancer Research Centres

9. Liquid Biopsy Market By Region

  • 9.1. Liquid Biopsy Market Outlook By Region
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. UK
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Russia
    • 9.3.7. Poland
    • 9.3.8. Rest of Europe
  • 9.4. Asia Pacific
    • 9.4.1. Japan
    • 9.4.2. China
    • 9.4.3. Australia
    • 9.4.4. India
    • 9.4.5. South Korea
    • 9.4.6. Southeast Asia
    • 9.4.7. Rest of APAC
  • 9.5. Latin America
    • 9.5.1. Brazil
    • 9.5.2. Argentina
    • 9.5.3. Venezuela
    • 9.5.4. Mexico
    • 9.5.5. Rest of Latin America
  • 9.6. Middle East & Africa
    • 9.6.1. Saudi Arabia
    • 9.6.2. South Africa
    • 9.6.3. Turkey
    • 9.6.4. UAE
    • 9.6.5. Rest of Middle East & Africa

10. Company Profiles

  • 10.1. Competitive Landscape: Liquid Biopsy Market
  • 10.2. Emerging Companies: Liquid Biopsy Market
  • 10.3. Menarini Silicon Biosystems
    • 10.3.1. Company Overview
    • 10.3.2. Menarini Group: Financials 2015-2018
    • 10.3.3. Menarini Silicon Biosystems Products
    • 10.3.4. Recent News
  • 10.4. MDxHealth SA
    • 10.4.1. Company Overview
    • 10.4.2. MDxHealth SA: Financials 2015-2019
    • 10.4.3. MDxHealth SA Products
    • 10.4.4. Recent News
  • 10.5. Biocept
    • 10.5.1. Company Overview
    • 10.5.2. Biocept: Financials 2015-2019
    • 10.5.3. Biocept Products
    • 10.5.4. Recent News
  • 10.6. Trovagene
    • 10.6.1. Company Overview
    • 10.6.2. Trovagene: Financials 2015-2019
    • 10.6.3. Trovagene Products
    • 10.6.4. Recent News
  • 10.7. Sysmex Corp
    • 10.7.1. Company Overview
    • 10.7.2. Sysmex Corp: Financials 2015-2019
    • 10.7.3. Sysmex Corp Products
    • 10.7.4. Recent News
  • 10.8. F. Hoffmann-La Roche AG
    • 10.8.1. Company Overview
    • 10.8.2. F. Hoffmann-La Roche AG: Financials 2015-2019
    • 10.8.3. F. Hoffmann-La Roche AG Products
    • 10.8.4. Recent News
  • 10.9. Bio-Rad Laboratories
    • 10.9.1. Company Overview
    • 10.9.2. Bio-Rad Laboratories: Financials 2015-2019
    • 10.9.3. Bio-Rad Laboratories Products
    • 10.9.4. Recent News
  • 10.10. Guardant Health
    • 10.10.1. Company Overview
    • 10.10.2. Guardant Health: Financials 2015-2019
    • 10.10.3. Guardant Health Products
    • 10.10.4. Recent News
  • 10.11. Illumina
    • 10.11.1. Company Overview
    • 10.11.2. Illumina: Financials 2015-2019
    • 10.11.3. Illumina Products
    • 10.11.4. Recent News
  • 10.12. Myriad Genetics
    • 10.12.1. Company Overview
    • 10.12.2. Myriad Genetics: Financials 2015-2019
    • 10.12.3. Myriad Genetics Products
    • 10.12.4. Recent News
  • 10.13. Qiagen N.V.
    • 10.13.1. Company Overview
    • 10.13.2. Qiagen N.V.: Financials 2015-2019
    • 10.13.3. Qiagen N.V. Products
    • 10.13.4. Recent News
  • 10.14. Lineage Cell Therapeutics
    • 10.14.1. Company Overview
    • 10.14.2. Lineage Cell Therapeutics: Financials 2015-2019
    • 10.14.3. Lineage Cell Therapeutics Products
    • 10.14.4. Recent News
  • 10.15. Abbott
    • 10.15.1. Company Overview
    • 10.15.2. Abbott Laboratories: Financials 2015-2019
    • 10.15.3. Abbott Laboratories Products
    • 10.15.4. Recent News
  • 10.16. Beckman Coulter (Danaher Corporation)
    • 10.16.1. Company Overview
    • 10.16.2. Danaher Corporation: Financials 2015-2019
    • 10.16.3. Beckman Coulter Products
    • 10.16.4. Recent News
  • 10.17. Caris Life Sciences
    • 10.17.1. Company Overview
    • 10.17.2. Caris Life Sciences Products
  • 10.18. OPKO Health
    • 10.18.1. Company Overview
    • 10.18.2. OPKO Health: Financials 2015-2019
    • 10.18.3. OPKO Health Products
    • 10.18.4. Recent News
  • 10.19. Thermo Fisher Scientific
    • 10.19.1. Company Overview
    • 10.19.2. Thermo Fisher Scientific: Financials 2015-2019
    • 10.19.3. Thermo Fisher Scientific Products
    • 10.19.4. Recent News
  • 10.20. Johnson & Johnson
    • 10.20.1. Company Overview
    • 10.20.2. Johnson & Johnson: Financials 2015-2019
    • 10.20.3. Johnson & Johnson Products
    • 10.20.4. Recent News
  • 10.21. Exact Sciences Corporation
    • 10.21.1. Company Overview
    • 10.21.2. Exact Sciences Corporation: Financials 2015-2019
    • 10.21.3. Exact Sciences Corporation Products
    • 10.21.4. Recent News
  • 10.22. Vermillion
    • 10.22.1. Company Overview
    • 10.22.2. Vermillion: Financials 2015-2019
    • 10.22.3. Vermillion Products
    • 10.22.4. Recent News

11. Conclusion & Recommendations

  • 11.1. COVID-19 Impact

12. Glossary

  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain

13. Appendix

  • 13.1. Visiongain report evaluation form
  • Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Tables

  • Table 1 Liquid Biopsy Market, 2020 - 2030 (USD Million)
  • Table 2 Liquid Biopsy Technologies for Screening and Early Detection
  • Table 3 Liquid Biopsy Market for Instruments, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 4 Liquid Biopsy Market for Instruments, 2020-2030 (USD Mn, AGR %, CAGR %) (VShaped Recovery)
  • Table 5 Liquid Biopsy Market for Instruments, 2020-2030 (USD Mn, AGR %, CAGR %) (UShaped Recovery)
  • Table 6 Liquid Biopsy Market for Instruments, 2020-2030 (USD Mn, AGR %, CAGR %) (LShaped Recovery)
  • Table 7 Liquid Biopsy Market for Instruments, 2020-2030 (USD Mn, AGR %, CAGR %) (WShaped Recovery)
  • Table 8 Liquid Biopsy Market for Kits & Reagents, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 9 Liquid Biopsy Market for Kits & Reagents, 2020-2030 (USD Mn, AGR %, CAGR %) (VShaped Recovery)
  • Table 10 Liquid Biopsy Market for Kits & Reagents, 2020-2030 (USD Mn, AGR %, CAGR %) (UShaped Recovery)
  • Table 11 Liquid Biopsy Market for Kits & Reagents, 2020-2030 (USD Mn, AGR %, CAGR %) (LShaped Recovery)
  • Table 12 Liquid Biopsy Market for Kits & Reagents, 2020-2030 (USD Mn, AGR %, CAGR %) (WShaped Recovery)
  • Table 13 Liquid Biopsy Market for Services, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 14 Liquid Biopsy Market for Services, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 15 Liquid Biopsy Market for Services, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 16 Liquid Biopsy Market for Services, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 17 Liquid Biopsy Market for Services, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 18 Liquid Biopsy Market for Blood Samples, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 19 Liquid Biopsy Market for Blood Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (VShaped Recovery)
  • Table 20 Liquid Biopsy Market for Blood Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (UShaped Recovery)
  • Table 21 Liquid Biopsy Market for Blood Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (LShaped Recovery)
  • Table 22 Liquid Biopsy Market for Blood Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (WShaped Recovery)
  • Table 23 Liquid Biopsy Market for Urine Samples, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 24 Liquid Biopsy Market for Urine Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (VShaped Recovery)
  • Table 25 Liquid Biopsy Market for Urine Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (UShaped Recovery)
  • Table 26 Liquid Biopsy Market for Urine Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (LShaped Recovery)
  • Table 27 Liquid Biopsy Market for Urine Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (WShaped Recovery)
  • Table 28 Liquid Biopsy Market for Other Samples, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 29 Liquid Biopsy Market for Other Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (VShaped Recovery)
  • Table 30 Liquid Biopsy Market for Other Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (UShaped Recovery)
  • Table 31 Liquid Biopsy Market for Other Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (LShaped Recovery)
  • Table 32 Liquid Biopsy Market for Other Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (WShaped Recovery)
  • Table 33 Liquid Biopsy Market for Circulating Tumour Cell (CTC), 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 34 Liquid Biopsy Market for Circulating Tumour Cell (CTC), 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 35 Liquid Biopsy Market for Circulating Tumour Cell (CTC), 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 36 Liquid Biopsy Market for Circulating Tumour Cell (CTC), 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 37 Liquid Biopsy Market for Circulating Tumour Cell (CTC), 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 38 Liquid Biopsy Market for Circulating Tumour DNA (ctDNA), 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 39 Liquid Biopsy Market for Circulating Tumour DNA (ctDNA), 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 40 Liquid Biopsy Market for Circulating Tumour DNA (ctDNA), 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 41 Liquid Biopsy Market for Circulating Tumour DNA (ctDNA), 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 42 Liquid Biopsy Market for Circulating Tumour DNA (ctDNA), 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 43 Liquid Biopsy Market for Exosomes, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 44 Liquid Biopsy Market for Exosomes, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 45 Liquid Biopsy Market for Exosomes, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 46 Liquid Biopsy Market for Exosomes, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 47 Liquid Biopsy Market for Exosomes, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 48 Liquid Biopsy Market for Other Biomarker, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 49 Liquid Biopsy Market for Other Biomarker, 2020-2030 (USD Mn, AGR %, CAGR %) (VShaped Recovery)
  • Table 50 Liquid Biopsy Market for Other Biomarker, 2020-2030 (USD Mn, AGR %, CAGR %) (UShaped Recovery)
  • Table 51 Liquid Biopsy Market for Other Biomarker, 2020-2030 (USD Mn, AGR %, CAGR %) (LShaped Recovery)
  • Table 52 Liquid Biopsy Market for Other Biomarker, 2020-2030 (USD Mn, AGR %, CAGR %) (WShaped Recovery)
  • Table 53 Liquid Biopsy Market for Breast Cancer, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 54 Liquid Biopsy Market for Breast Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (VShaped Recovery)
  • Table 55 Liquid Biopsy Market for Breast Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (UShaped Recovery)
  • Table 56 Liquid Biopsy Market for Breast Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (LShaped Recovery)
  • Table 57 Liquid Biopsy Market for Breast Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (WShaped Recovery)
  • Table 58 Liquid Biopsy Market for Colorectal Cancer, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 59 Liquid Biopsy Market for Colorectal Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (VShaped Recovery)
  • Table 60 Liquid Biopsy Market for Colorectal Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (UShaped Recovery)
  • Table 61 Liquid Biopsy Market for Colorectal Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (LShaped Recovery)
  • Table 62 Liquid Biopsy Market for Colorectal Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (WShaped Recovery)
  • Table 63 Liquid Biopsy Market for Liver Cancer, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 64 Liquid Biopsy Market for Liver Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (VShaped Recovery)
  • Table 65 Liquid Biopsy Market for Liver Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (UShaped Recovery)
  • Table 66 Liquid Biopsy Market for Liver Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (LShaped Recovery)
  • Table 67 Liquid Biopsy Market for Liver Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (WShaped Recovery)
  • Table 68 Liquid Biopsy Market for Lung Cancer, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 69 Liquid Biopsy Market for Lung Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (VShaped Recovery)
  • Table 70 Liquid Biopsy Market for Lung Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (UShaped Recovery)
  • Table 71 Liquid Biopsy Market for Lung Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (LShaped Recovery)
  • Table 72 Liquid Biopsy Market for Lung Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (WShaped Recovery)
  • Table 73 Liquid Biopsy Market for Prostate Cancer, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 74 Liquid Biopsy Market for Prostate Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (VShaped Recovery)
  • Table 75 Liquid Biopsy Market for Prostate Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (UShaped Recovery)
  • Table 76 Liquid Biopsy Market for Prostate Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (LShaped Recovery)
  • Table 77 Liquid Biopsy Market for Prostate Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (WShaped Recovery)
  • Table 78 Liquid Biopsy Market for Other Cancers, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 79 Liquid Biopsy Market for Other Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (VShaped Recovery)
  • Table 80 Liquid Biopsy Market for Other Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (UShaped Recovery)
  • Table 81 Liquid Biopsy Market for Other Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (LShaped Recovery)
  • Table 82 Liquid Biopsy Market for Other Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (WShaped Recovery)
  • Table 83 Liquid Biopsy Market for Hospitals, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 84 Liquid Biopsy Market for Hospitals, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 85 Liquid Biopsy Market for Hospitals, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 86 Liquid Biopsy Market for Hospitals, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 87 Liquid Biopsy Market for Hospitals, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 88 Liquid Biopsy Market for Diagnostic Laboratories, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 89 Liquid Biopsy Market for Diagnostic Laboratories, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 90 Liquid Biopsy Market for Diagnostic Laboratories, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 91 Liquid Biopsy Market for Diagnostic Laboratories, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 92 Liquid Biopsy Market for Diagnostic Laboratories, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 93 Liquid Biopsy Market for Academic Institutions, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 94 Liquid Biopsy Market for Academic Institutions, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 95 Liquid Biopsy Market for Academic Institutions, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 96 Liquid Biopsy Market for Academic Institutions, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 97 Liquid Biopsy Market for Academic Institutions, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 98 Liquid Biopsy Market for Cancer Research Centres, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 99 Liquid Biopsy Market for Cancer Research Centres, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 100 Liquid Biopsy Market for Cancer Research Centres, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 101 Liquid Biopsy Market for Cancer Research Centres, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 102 Liquid Biopsy Market for Cancer Research Centres, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 103 North America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 104 North America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (VShaped Recovery)
  • Table 105 North America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (UShaped Recovery)
  • Table 106 North America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (LShaped Recovery)
  • Table 107 North America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (WShaped Recovery)
  • Table 108 North America Liquid Biopsy Market By Sample Type, 2020 - 2030 (USD Mn)
  • Table 109 North America Liquid Biopsy Market By Product, 2020 - 2030 (USD Mn)
  • Table 110 North America Liquid Biopsy Market By Biomarker, 2020 - 2030 (USD Mn)
  • Table 111 North America Liquid Biopsy Market By Cancer Type, 2020 - 2030 (USD Mn)
  • Table 112 North America Liquid Biopsy Market By End-User, 2020 - 2030 (USD Mn)
  • Table 113 U.S. Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 114 U.S. Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 115 U.S. Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 116 U.S. Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 117 U.S. Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 118 Canada Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 119 Canada Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 120 Canada Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 121 Canada Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 122 Canada Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 123 Europe Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 124 Europe Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 125 Europe Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 126 Europe Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 127 Europe Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 128 Europe Liquid Biopsy Market By Sample Type, 2020 - 2030 (USD Mn)
  • Table 129 Europe Liquid Biopsy Market By Product, 2020 - 2030 (USD Mn)
  • Table 130 Europe Liquid Biopsy Market By Biomarker, 2020 - 2030 (USD Mn)
  • Table 131 Europe Liquid Biopsy Market By Cancer Type, 2020 - 2030 (USD Mn)
  • Table 132 Europe Liquid Biopsy Market By End-User, 2020 - 2030 (USD Mn)
  • Table 133 Germany Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 134 Germany Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 135 Germany Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 136 Germany Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 137 Germany Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 138 France Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 139 France Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 140 France Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 141 France Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 142 France Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 143 UK Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 144 UK Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 145 UK Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 146 UK Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 147 UK Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 148 Italy Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 149 Italy Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 150 Italy Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 151 Italy Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 152 Italy Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 153 Spain Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 154 Spain Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 155 Spain Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 156 Spain Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 157 Spain Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 158 Russia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 159 Russia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 160 Russia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 161 Russia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 162 Russia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 163 Poland Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 164 Poland Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 165 Poland Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 166 Poland Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 167 Poland Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 168 Rest of Europe Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 169 Rest of Europe Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (VShaped Recovery)
  • Table 170 Rest of Europe Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (UShaped Recovery)
  • Table 171 Rest of Europe Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (LShaped Recovery)
  • Table 172 Rest of Europe Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (WShaped Recovery)
  • Table 173 Asia Pacific Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 174 Asia Pacific Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 175 Asia Pacific Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 176 Asia Pacific Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 177 Asia Pacific Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (WShaped Recovery)
  • Table 178 Asia Pacific Liquid Biopsy Market By Sample Type, 2020 - 2030 (USD Mn)
  • Table 179 Asia Pacific Liquid Biopsy Market By Product, 2020 - 2030 (USD Mn)
  • Table 180 Asia Pacific Liquid Biopsy Market By Biomarker, 2020 - 2030 (USD Mn)
  • Table 181 Asia Pacific Liquid Biopsy Market By Cancer Type, 2020 - 2030 (USD Mn)
  • Table 182 Asia Pacific Liquid Biopsy Market By End-User, 2020 - 2030 (USD Mn)
  • Table 183 Japan Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 184 Japan Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 185 Japan Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 186 Japan Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 187 Japan Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 188 China Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 189 China Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 190 China Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 191 China Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 192 China Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 193 Australia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 194 Australia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 195 Australia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 196 Australia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 197 Australia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 198 India Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 199 India Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 200 India Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 201 India Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 202 India Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 203 South Korea Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 204 South Korea Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (VShaped Recovery)
  • Table 205 South Korea Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (UShaped Recovery)
  • Table 206 South Korea Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (LShaped Recovery)
  • Table 207 South Korea Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (WShaped Recovery)
  • Table 208 Southeast Asia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 209 Southeast Asia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (VShaped Recovery)
  • Table 210 Southeast Asia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (UShaped Recovery)
  • Table 211 Southeast Asia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (LShaped Recovery)
  • Table 212 Southeast Asia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (WShaped Recovery)
  • Table 213 Rest of APAC Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 214 Rest of Asia Pacific Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (VShaped Recovery)
  • Table 215 Rest of Asia Pacific Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (UShaped Recovery)
  • Table 216 Rest of Asia Pacific Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (LShaped Recovery)
  • Table 217 Rest of Asia Pacific Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 218 Latin America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 219 Latin America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (VShaped Recovery)
  • Table 220 Latin America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (UShaped Recovery)
  • Table 221 Latin America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (LShaped Recovery)
  • Table 222 Latin America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (WShaped Recovery)
  • Table 223 Latin America Liquid Biopsy Market By Sample Type, 2020 - 2030 (USD Mn)
  • Table 224 Latin America Liquid Biopsy Market By Product, 2020 - 2030 (USD Mn)
  • Table 225 Latin America Liquid Biopsy Market By Biomarker, 2020 - 2030 (USD Mn)
  • Table 226 Latin America Liquid Biopsy Market By Cancer Type, 2020 - 2030 (USD Mn)
  • Table 227 Latin America Liquid Biopsy Market By End-User, 2020 - 2030 (USD Mn)
  • Table 228 Brazil Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 229 Brazil Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 230 Brazil Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 231 Brazil Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 232 Brazil Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 233 Argentina Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 234 Argentina Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 235 Argentina Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 236 Argentina Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 237 Argentina Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 238 Venezuela Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 239 Venezuela Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 240 Venezuela Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 241 Venezuela Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 242 Venezuela Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 243 Mexico Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 244 Mexico Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 245 Mexico Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 246 Mexico Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 247 Mexico Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 248 Rest of LA Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 249 Rest of Latin America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 250 Rest of Latin America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 251 Rest of Latin America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 252 Rest of Latin America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 253 Middle East & Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 254 Middle East & Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 255 Middle East & Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 256 Middle East & Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 257 Middle East & Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 258 Middle East & Africa Liquid Biopsy Market By Sample Type, 2020 - 2030 (USD Mn)
  • Table 259 Middle East & Africa Liquid Biopsy Market By Product, 2020 - 2030 (USD Mn)
  • Table 260 Middle East & Africa Liquid Biopsy Market By Biomarker, 2020 - 2030 (USD Mn)
  • Table 261 Middle East & Africa Liquid Biopsy Market By Cancer Type, 2020 - 2030 (USD Mn)
  • Table 262 Middle East & Africa Liquid Biopsy Market By End-User, 2020 - 2030 (USD Mn)
  • Table 263 Saudi Arabia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 264 Saudi Arabia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (VShaped Recovery)
  • Table 265 Saudi Arabia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (UShaped Recovery)
  • Table 266 Saudi Arabia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (LShaped Recovery)
  • Table 267 Saudi Arabia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (WShaped Recovery)
  • Table 268 South Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 269 South Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (VShaped Recovery)
  • Table 270 South Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (UShaped Recovery)
  • Table 271 South Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (LShaped Recovery)
  • Table 272 South Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (WShaped Recovery)
  • Table 273 Turkey Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 274 Turkey Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 275 Turkey Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 276 Turkey Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 277 Turkey Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 278 UAE Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 279 UAE Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 280 UAE Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 281 UAE Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 282 UAE Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 283 Rest of MEA Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
  • Table 284 Rest of Middle East & Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
  • Table 285 Rest of Middle East & Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
  • Table 286 Rest of Middle East & Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
  • Table 287 Rest of Middle East & Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
  • Table 288 Emerging Liquid Biopsy Companies
  • Table 289 Menarini Silicon Biosystems: Key Details 2020 (Headquarter, Founded, Employees, Company Type, Website, Business Segment)
  • Table 290 Menarini Silicon Biosystems: Products
  • Table 291 Menarini Silicon Biosystems: Recent Developments (Date, Type, Details)
  • Table 292 MDxHealth SA: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 293 MDxHealth SA: Products
  • Table 294 MDxHealth SA: Recent Developments (Date, Type, Details)
  • Table 295 Biocept: Key Details 2020 (CEO, Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 296 Biocept: Products
  • Table 297 Biocept: Recent Developments (Date, Type, Details)
  • Table 298 Trovagene: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Technology)
  • Table 299 Trovagene: Products
  • Table 300 Trovagene: Recent Developments (Date, Type, Details)
  • Table 301 Sysmex Corporation: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 302 Sysmex Corp: Products
  • Table 303 Sysmex Corp: Recent Developments (Date, Type, Details)
  • Table 304 F. Hoffmann-La Roche AG: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 305 F. Hoffmann-La Roche AG: Products
  • Table 306 F. Hoffmann-La Roche AG: Recent Developments (Date, Type, Details)
  • Table 307 Bio-Rad Laboratories: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 308 Bio-Rad Laboratories: Products
  • Table 309 Bio-Rad Laboratories: Recent Developments (Date, Type, Details)
  • Table 310 Guardant Health: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 311 Guardant Health: Products
  • Table 312 Guardant Health: Recent Developments (Date, Type, Details)
  • Table 313 Illumina: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 314 Illumina: Products
  • Table 315 Illumina: Recent Developments (Date, Type, Details)
  • Table 316 Myriad Genetics: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 317 Myriad Genetics: Products
  • Table 318 Myriad Genetics: Recent Developments (Date, Type, Details)
  • Table 319 Qiagen N.V.: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 320 Qiagen N.V.: Products
  • Table 321 Qiagen N.V.: Recent Developments (Date, Type, Details)
  • Table 322 Lineage Cell Therapeutics: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 323 Lineage Cell Therapeutics: Products
  • Table 324 Lineage Cell Therapeutics: Recent Developments (Date, Type, Details)
  • Table 325 Abbott Laboratories: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 326 Abbott Laboratories: Products
  • Table 327 Abbott Laboratories: Recent Developments (Date, Type, Details)
  • Table 328 Beckman Coulter: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 329 Beckman Coulter: Products
  • Table 330 Beckman Coulter: Recent Developments (Date, Type, Details)
  • Table 331 Caris Life Sciences: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 332 Caris Life Sciences: Products
  • Table 333 OPKO Health: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 334 OPKO Health: Products
  • Table 335 OPKO Health: Recent Developments (Date, Type, Details)
  • Table 336 Thermo Fisher Scientific: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 337 Thermo Fisher Scientific: Products
  • Table 338 Thermo Fisher Scientific: Recent Developments (Date, Type, Details)
  • Table 339 Johnson & Johnson: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 340 Johnson & Johnson: Products
  • Table 341 Johnson & Johnson: Recent Developments (Date, Type, Details)
  • Table 342 Exact Sciences Corporation: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 343 Exact Sciences Corporation: Products
  • Table 344 Exact Sciences Corporation: Recent Developments (Date, Type, Details)
  • Table 345 Vermillion: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 346 Vermillion: Products
  • Table 347 Vermillion: Recent Developments (Date, Type, Details)

List of Figures

  • FIG.1 Market Segmentation & Scope
  • FIG.2 Liquid Biopsy Industry: Drivers
  • FIG.3 Worldwide Cancer Death by Age, 2018 (%)
  • FIG.4 Share of population with cancer, 2018 (%)
  • FIG.5 Ageing Population Estimates 2010 - 2050
  • FIG.6 Liquid Biopsy Industry: Restraints
  • FIG.7 Liquid Biopsy Industry: Opportunities
  • FIG.8 Timeline of FDA Approvals and Breakthrough Device Designations
  • FIG.9 Liquid Biopsy Industry: Latest developments
  • FIG.10 Global Liquid Biopsy Market Size By Product, 2020 - 2030 (USD Million, AGR %)
  • FIG.11 Global Liquid Biopsy Market Size By Product, 2020 - 2030 (USD Million, AGR %) (VShaped Recovery)
  • FIG.12 Global Liquid Biopsy Market Size By Product, 2020 - 2030 (USD Million, AGR %) (UShaped Recovery)
  • FIG.13 Global Liquid Biopsy Market Size By Product, 2020 - 2030 (USD Million, AGR %) (LShaped Recovery)
  • FIG.14 Global Liquid Biopsy Market Size By Product, 2020 - 2030 (USD Million, AGR %) (WShaped Recovery)
  • FIG.15 Global Liquid Biopsy Market Share By Product, 2020, 2025, 2030 (%)
  • FIG.16 Liquid Biopsy for Instruments Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.17 Liquid Biopsy for Instruments Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (VShaped Recovery)
  • FIG.18 Liquid Biopsy for Instruments Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (UShaped Recovery)
  • FIG.19 Liquid Biopsy for Instruments Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (LShaped Recovery)
  • FIG.20 Liquid Biopsy for Instruments Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (WShaped Recovery)
  • FIG.21 Liquid Biopsy for Kits & Reagents Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.22 Liquid Biopsy for Kits & Reagents Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.23 Liquid Biopsy for Kits & Reagents Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.24 Liquid Biopsy for Kits & Reagents Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.25 Liquid Biopsy for Kits & Reagents Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.26 Liquid Biopsy for Services Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.27 Liquid Biopsy for Services Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (VShaped Recovery)
  • FIG.28 Liquid Biopsy for Services Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (UShaped Recovery)
  • FIG.29 Liquid Biopsy for Services Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (LShaped Recovery)
  • FIG.30 Liquid Biopsy for Services Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (WShaped Recovery)
  • FIG.31 Global Liquid Biopsy Market Size By Sample Type, 2020 - 2030 (USD Million, AGR %)
  • FIG.32 Global Liquid Biopsy Market Size By Sample Type, 2020 - 2030 (USD Million, AGR %) (VShaped Recovery)
  • FIG.33 Global Liquid Biopsy Market Size By Sample Type, 2020 - 2030 (USD Million, AGR %) (UShaped Recovery)
  • FIG.34 Global Liquid Biopsy Market Size By Sample Type, 2020 - 2030 (USD Million, AGR %) (LShaped Recovery)
  • FIG.35 Global Liquid Biopsy Market Size By Sample Type, 2020 - 2030 (USD Million, AGR %) (WShaped Recovery)
  • FIG.36 Global Liquid Biopsy Market Share By Sample Type, 2020, 2025, 2030 (%)
  • FIG.37 Liquid Biopsy for Blood Samples Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.38 Liquid Biopsy for Blood Samples Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.39 Liquid Biopsy for Blood Samples Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.40 Liquid Biopsy for Blood Samples Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.41 Liquid Biopsy for Blood Samples Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.42 Liquid Biopsy for Urine Samples Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.43 Liquid Biopsy for Urine Samples Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.44 Liquid Biopsy for Urine Samples Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.45 Liquid Biopsy for Urine Samples Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.46 Liquid Biopsy for Urine Samples Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.47 Liquid Biopsy for Other Samples Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.48 Liquid Biopsy for Other Samples Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.49 Liquid Biopsy for Other Samples Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.50 Liquid Biopsy for Other Samples Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.51 Liquid Biopsy for Other Samples Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.52 Global Liquid Biopsy Market Size By Biomarker, 2020 - 2030 (USD Million, AGR %)
  • FIG.53 Global Liquid Biopsy Market Size By Biomarker, 2020 - 2030 (USD Million, AGR %) (VShaped Recovery)
  • FIG.54 Global Liquid Biopsy Market Size By Biomarker, 2020 - 2030 (USD Million, AGR %) (UShaped Recovery)
  • FIG.55 Global Liquid Biopsy Market Size By Biomarker, 2020 - 2030 (USD Million, AGR %) (LShaped Recovery)
  • FIG.56 Global Liquid Biopsy Market Size By Biomarker, 2020 - 2030 (USD Million, AGR %) (WShaped Recovery)
  • FIG.57 Global Liquid Biopsy Market Share By Biomarker, 2020, 2025, 2030 (%)
  • FIG.58 Liquid Biopsy for Circulating Tumour Cell (CTC) Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.59 Liquid Biopsy for Circulating Tumour Cell (CTC) Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.60 Liquid Biopsy for Circulating Tumour Cell (CTC) Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.61 Liquid Biopsy for Circulating Tumour Cell (CTC) Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.62 Liquid Biopsy for Circulating Tumour Cell (CTC) Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.63 Liquid Biopsy for Circulating Tumour DNA (ctDNA) Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.64 Liquid Biopsy for Circulating Tumour DNA (ctDNA) Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.65 Liquid Biopsy for Circulating Tumour DNA (ctDNA) Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.66 Liquid Biopsy for Circulating Tumour DNA (ctDNA) Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.67 Liquid Biopsy for Circulating Tumour DNA (ctDNA) Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.68 Liquid Biopsy for Exosomes Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.69 Liquid Biopsy for Exosomes Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (VShaped Recovery)
  • FIG.70 Liquid Biopsy for Exosomes Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (UShaped Recovery)
  • FIG.71 Liquid Biopsy for Exosomes Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (LShaped Recovery)
  • FIG.72 Liquid Biopsy for Exosomes Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (WShaped Recovery)
  • FIG.73 Liquid Biopsy for Other Biomarker Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.74 Liquid Biopsy for Other Biomarker Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.75 Liquid Biopsy for Other Biomarker Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.76 Liquid Biopsy for Other Biomarker Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.77 Liquid Biopsy for Other Biomarker Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.78 Global Liquid Biopsy Market Size By Cancer Type, 2020 - 2030 (USD Million, AGR %)
  • FIG.79 Global Liquid Biopsy Market Size By Cancer Type, 2020 - 2030 (USD Million, AGR %) (VShaped Recovery)
  • FIG.80 Global Liquid Biopsy Market Size By Cancer Type, 2020 - 2030 (USD Million, AGR %) (UShaped Recovery)
  • FIG.81 Global Liquid Biopsy Market Size By Cancer Type, 2020 - 2030 (USD Million, AGR %) (LShaped Recovery)
  • FIG.82 Global Liquid Biopsy Market Size By Cancer Type, 2020 - 2030 (USD Million, AGR %) (WShaped Recovery)
  • FIG.83 Global Liquid Biopsy Market Share By Cancer Type, 2020, 2025, 2030 (%)
  • FIG.84 Liquid Biopsy for Breast Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.85 Liquid Biopsy for Breast Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.86 Liquid Biopsy for Breast Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.87 Liquid Biopsy for Breast Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (LShaped Recovery)
  • FIG.88 Liquid Biopsy for Breast Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.89 Liquid Biopsy for Colorectal Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.90 Liquid Biopsy for Colorectal Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.91 Liquid Biopsy for Colorectal Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.92 Liquid Biopsy for Colorectal Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.93 Liquid Biopsy for Colorectal Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.94 Liquid Biopsy for Liver Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.95 Liquid Biopsy for Liver Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (VShaped Recovery)
  • FIG.96 Liquid Biopsy for Liver Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (UShaped Recovery)
  • FIG.97 Liquid Biopsy for Liver Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (LShaped Recovery)
  • FIG.98 Liquid Biopsy for Liver Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (WShaped Recovery)
  • FIG.99 Liquid Biopsy for Lung Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.100 Liquid Biopsy for Lung Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.101 Liquid Biopsy for Lung Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.102 Liquid Biopsy for Lung Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.103 Liquid Biopsy for Lung Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.104 Liquid Biopsy for Prostate Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.105 Liquid Biopsy for Prostate Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.106 Liquid Biopsy for Prostate Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.107 Liquid Biopsy for Prostate Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.108 Liquid Biopsy for Prostate Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.109 Liquid Biopsy for Other Cancers Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.110 Liquid Biopsy for Other Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.111 Liquid Biopsy for Other Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.112 Liquid Biopsy for Other Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.113 Liquid Biopsy for Other Cancer Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.114 Global Liquid Biopsy Market Size By End-User, 2020 - 2030 (USD Million, AGR %)
  • FIG.115 Global Liquid Biopsy Market Size By End-User, 2020 - 2030 (USD Million, AGR %) (VShaped Recovery)
  • FIG.116 Global Liquid Biopsy Market Size By End-User, 2020 - 2030 (USD Million, AGR %) (UShaped Recovery)
  • FIG.117 Global Liquid Biopsy Market Size By End-User, 2020 - 2030 (USD Million, AGR %) (LShaped Recovery)
  • FIG.118 Global Liquid Biopsy Market Size By End-User, 2020 - 2030 (USD Million, AGR %) (WShaped Recovery)
  • FIG.119 Global Liquid Biopsy Market Share By End-User, 2020, 2025, 2030 (%)
  • FIG.120 Liquid Biopsy for Hospitals Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.121 Liquid Biopsy for Hospitals Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (VShaped Recovery)
  • FIG.122 Liquid Biopsy for Hospitals Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (UShaped Recovery)
  • FIG.123 Liquid Biopsy for Hospitals Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (LShaped Recovery)
  • FIG.124 Liquid Biopsy for Hospitals Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (WShaped Recovery)
  • FIG.125 Liquid Biopsy for Diagnostic Laboratories Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.126 Liquid Biopsy for Diagnostic Laboratories Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.127 Liquid Biopsy for Diagnostic Laboratories Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.128 Liquid Biopsy for Diagnostic Laboratories Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.129 Liquid Biopsy for Diagnostic Laboratories Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.130 Liquid Biopsy for Academic Institutions Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.131 Liquid Biopsy for Academic Institutions Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.132 Liquid Biopsy for Academic Institutions Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.133 Liquid Biopsy for Academic Institutions Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.134 Liquid Biopsy for Academic Institutions Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.135 Liquid Biopsy for Cancer Research Centres Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.136 Liquid Biopsy for Cancer Research Centres Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.137 Liquid Biopsy for Cancer Research Centres Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.138 Liquid Biopsy for Cancer Research Centres Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.139 Liquid Biopsy for Cancer Research Centres Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.140 Global Liquid Biopsy Market Size By Region, 2020 - 2030 (USD Million, AGR %)
  • FIG.141 Global Liquid Biopsy Market Size By Region, 2020 - 2030 (USD Million, AGR %) (VShaped Recovery)
  • FIG.142 Global Liquid Biopsy Market Size By Region, 2020 - 2030 (USD Million, AGR %) (UShaped Recovery)
  • FIG.143 Global Liquid Biopsy Market Size By Region, 2020 - 2030 (USD Million, AGR %) (LShaped Recovery)
  • FIG.144 Global Liquid Biopsy Market Size By Region, 2020 - 2030 (USD Million, AGR %) (WShaped Recovery)
  • FIG.145 Global Liquid Biopsy Market Share By Region, 2020, 2025, 2030 (%)
  • FIG.146 North America Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.147 North America Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (VShaped Recovery)
  • FIG.148 North America Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (UShaped Recovery)
  • FIG.149 North America Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (LShaped Recovery)
  • FIG.150 North America Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (WShaped Recovery)
  • FIG.151 North America Liquid Biopsy Market Share By Country, 2020, 2025, 2030 (%)
  • FIG.152 U.S. Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.153 U.S. Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.154 U.S. Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.155 U.S. Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.156 U.S. Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.157 Canada Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.158 Canada Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (VShaped Recovery)
  • FIG.159 Canada Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (UShaped Recovery)
  • FIG.160 Canada Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (LShaped Recovery)
  • FIG.161 Canada Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (WShaped Recovery)
  • FIG.162 Europe Liquid Biopsy Market Share By Country, 2020, 2025, 2030 (%)
  • FIG.163 Europe Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.164 Europe Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.165 Europe Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (UShaped Recovery)
  • FIG.166 Europe Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.167 Europe Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (WShaped Recovery)
  • FIG.168 Germany Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.169 Germany Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (VShaped Recovery)
  • FIG.170 Germany Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (UShaped Recovery)
  • FIG.171 Germany Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (LShaped Recovery)
  • FIG.172 Germany Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (WShaped Recovery)
  • FIG.173 France Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.174 France Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.175 France Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.176 France Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.177 France Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (WShaped Recovery)
  • FIG.178 UK Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.179 UK Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.180 UK Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.181 UK Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.182 UK Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.183 Italy Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.184 Italy Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.185 Italy Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.186 Italy Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.187 Italy Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.188 Spain Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.189 Spain Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.190 Spain Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.191 Spain Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.192 Spain Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.193 Russia Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.194 Russia Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.195 Russia Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.196 Russia Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.197 Russia Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (WShaped Recovery)
  • FIG.198 Poland Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.199 Poland Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.200 Poland Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.201 Poland Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.202 Poland Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (WShaped Recovery)
  • FIG.203 Rest of Europe Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.204 Rest of Europe Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (VShaped Recovery)
  • FIG.205 Rest of Europe Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.206 Rest of Europe Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (LShaped Recovery)
  • FIG.207 Rest of Europe Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.208 Asia Pacific Liquid Biopsy Market Share By Country, 2020, 2025, 2030 (%)
  • FIG.209 Asia Pacific Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.210 Asia Pacific Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (VShaped Recovery)
  • FIG.211 Asia Pacific Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (UShaped Recovery)
  • FIG.212 Asia Pacific Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (LShaped Recovery)
  • FIG.213 Asia Pacific Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (WShaped Recovery)
  • FIG.214 Japan Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.215 Japan Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.216 Japan Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.217 Japan Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.218 Japan Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.219 China Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.220 China Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.221 China Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.222 China Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.223 China Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.224 Australia Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.225 Australia Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (VShaped Recovery)
  • FIG.226 Australia Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (UShaped Recovery)
  • FIG.227 Australia Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (LShaped Recovery)
  • FIG.228 Australia Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (WShaped Recovery)
  • FIG.229 India Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.230 India Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.231 India Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.232 India Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.233 India Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.234 Korean Developers of Liquid Biopsy Technology
  • FIG.235 South Korea Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.236 South Korea Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (VShaped Recovery)
  • FIG.237 South Korea Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (UShaped Recovery)
  • FIG.238 South Korea Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (LShaped Recovery)
  • FIG.239 South Korea Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (WShaped Recovery)
  • FIG.240 Southeast Asia Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.241 Southeast Asia Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.242 Southeast Asia Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.243 Southeast Asia Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (LShaped Recovery)
  • FIG.244 Southeast Asia Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.245 Rest of APAC Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.246 Rest of Asia Pacific Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.247 Rest of Asia Pacific Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.248 Rest of Asia Pacific Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.249 Rest of Asia Pacific Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.250 Latin America Liquid Biopsy Market Share By Country, 2020, 2025, 2030 (%)
  • FIG.251 Latin America Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.252 Latin America Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (VShaped Recovery)
  • FIG.253 Latin America Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (UShaped Recovery)
  • FIG.254 Latin America Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (LShaped Recovery)
  • FIG.255 Latin America Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (WShaped Recovery)
  • FIG.256 Brazil Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.257 Brazil Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.258 Brazil Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.259 Brazil Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.260 Brazil Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.261 Argentina Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.262 Argentina Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (VShaped Recovery)
  • FIG.263 Argentina Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (UShaped Recovery)
  • FIG.264 Argentina Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (LShaped Recovery)
  • FIG.265 Argentina Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (WShaped Recovery)
  • FIG.266 Venezuela Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.267 Venezuela Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (VShaped Recovery)
  • FIG.268 Venezuela Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (UShaped Recovery)
  • FIG.269 Venezuela Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (LShaped Recovery)
  • FIG.270 Venezuela Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (WShaped Recovery)
  • FIG.271 Mexico Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.272 Number of cancer deaths in Mexico in 2018, by cancer type
  • FIG.273 Mexico Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.274 Mexico Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.275 Mexico Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.276 Mexico Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (WShaped Recovery)
  • FIG.277 Rest of LA Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.278 Rest of Latin America Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.279 Rest of Latin America Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.280 Rest of Latin America Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.281 Rest of Latin America Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.282 Middle East & Africa Liquid Biopsy Market Share By Country, 2020, 2025, 2030 (%)
  • FIG.283 Middle East & Africa Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.284 Middle East & Africa Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.285 Middle East & Africa Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.286 Middle East & Africa Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.287 Middle East & Africa Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.288 Saudi Arabia Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.289 Saudi Arabia Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (VShaped Recovery)
  • FIG.290 Saudi Arabia Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (UShaped Recovery)
  • FIG.291 Saudi Arabia Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (LShaped Recovery)
  • FIG.292 Saudi Arabia Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (WShaped Recovery)
  • FIG.293 South Africa Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.294 South Africa Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (VShaped Recovery)
  • FIG.295 South Africa Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (UShaped Recovery)
  • FIG.296 South Africa Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (LShaped Recovery)
  • FIG.297 South Africa Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (WShaped Recovery)
  • FIG.298 Turkey Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.299 Turkey Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.300 Turkey Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.301 Turkey Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.302 Turkey Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (WShaped Recovery)
  • FIG.303 UAE Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.304 UAE Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.305 UAE Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.306 UAE Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.307 UAE Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.308 Rest of MEA Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %)
  • FIG.309 Rest of Middle East & Africa Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (V-Shaped Recovery)
  • FIG.310 Rest of Middle East & Africa Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (U-Shaped Recovery)
  • FIG.311 Rest of Middle East & Africa Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (L-Shaped Recovery)
  • FIG.312 Rest of Middle East & Africa Liquid Biopsy Market Value Forecast, 2020 - 2030 (USD Mn, AGR %) (W-Shaped Recovery)
  • FIG.313 Top Companies in Liquid Biopsy Market
  • FIG.314 Liquid Biopsy Market: Company Market Positioning
  • FIG.315 Menarini Group: Financials, 2015-2018 (US$ million, AGR %)
  • FIG.316 MDxHealth SA: Financials, 2015-2019 (US$ million, AGR %)
  • FIG.317 Biocept: Financials, 2015-2019 (US$ thousand, AGR %)
  • FIG.318 Trovagene: Financials, 2015-2019 (US$ thousand, AGR %)
  • FIG.319 Sysmex Corp: Financials, 2015-2019 (US$ million, AGR %)
  • FIG.320 Sysmex Corp: Business Segment, 2019 (%)
  • FIG.321 Sysmex Corp: Regional Sales, 2019 (%)
  • FIG.322 F. Hoffmann-La Roche AG: Financials, 2015-2019 (US$ thousand, AGR %)
  • FIG.323 F. Hoffmann-La Roche AG: Business Segment, 2019 (%)
  • FIG.324 F. Hoffmann-La Roche AG: Pharmaceuticals Division - Sales by Therapeutic Area, 2019 (%)
  • FIG.325 F. Hoffmann-La Roche AG: Oncology Division - Sales by Product, 2019 (%)
  • FIG.326 Bio-Rad Laboratories : Financials, 2015-2019 (US$ million, AGR %)
  • FIG.327 Bio-Rad Laboratories: Business Segment, 2019 (%)
  • FIG.328 Bio-Rad Laboratories: Regional Sales, 2019 (%)
  • FIG.329 Guardant Health: Financials, 2015-2019 (US$ million, AGR %)
  • FIG.330 Guardant Health: Business Segment, 2019 (%)
  • FIG.331 Illumina: Financials, 2015-2019 (US$ million, AGR %)
  • FIG.332 Illumina: Business Segment, 2019 (%)
  • FIG.333 Illumina: Regional Sales, 2019 (%)
  • FIG.334 Myriad Genetics: Financials, 2015-2019 (US$ million, AGR %)
  • FIG.335 Myriad Genetics: Business Segment, 2019 (%)
  • FIG.336 Qiagen N.V.: Financials, 2015-2019 (US$ million, AGR %)
  • FIG.337 Qiagen N.V.: Business Segment, 2019 (%)
  • FIG.338 Qiagen N.V.: Regional Sales, 2019 (%)
  • FIG.339 Lineage Cell Therapeutics: Financials, 2015-2019 (US$ million, AGR %)
  • FIG.340 Abbott Laboratories: Financials, 2015-2019 (US$ million, AGR %)
  • FIG.341 Abbott: Business Segment, 2019 (%)
  • FIG.342 Abbott: Regional Sales, 2019 (%)
  • FIG.343 Danaher Corporation: Financials, 2015-2019 (US$ million, AGR %)
  • FIG.344 Danaher Corporation: Business Segment, 2019 (%)
  • FIG.345 Danaher Corporation: Regional Sales, 2019 (%)
  • FIG.346 OPKO Health : Financials, 2015-2019 (US$ million, AGR %)
  • FIG.347 OPKO Health: Business Segment, 2019 (%)
  • FIG.348 OPKO Health: Regional Sales, 2019 (%)
  • FIG.349 Thermo Fisher Scientific: Financials, 2015-2019 (US$ thousand, AGR %)
  • FIG.350 Thermo Fisher Scientific: Business Segment, 2019 (%)
  • FIG.351 Johnson & Johnson: Financials, 2015-2019 (US$ million, AGR %)
  • FIG.352 Johnson & Johnson: Business Segment, 2019 (%)
  • FIG.353 Johnson & Johnson: Regional Sales, 2019 (%)
  • FIG.354 Exact Sciences Corporation: Financials, 2015-2019 (US$ million, AGR %)
  • FIG.355 Exact Sciences Corporation: Business Segment, 2019 (%)
  • FIG.356 Vermillion: Financials, 2015-2019 (US$ thousand, AGR %)
  • FIG.357 Vermillion: Business Segment, 2019 (%)